Literature DB >> 25650090

Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.

X Chen1, L F Newell2, H Xie3, R B Walter4, J M Pagel5, V K Sandhu3, P S Becker4, P C Hendrie6, J L Abkowitz6, F R Appelbaum5, E H Estey4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25650090     DOI： 10.1038/leu.2015.23

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia.

Authors:  F Stölzel; U Platzbecker; B Mohr; C Röllig; J M Middeke; C Thiede; M Füssel; M Hänel; M Schaich; G Ehninger; J Schetelig; M Bornhäuser
Journal:  Leukemia       Date:  2013-05-07       Impact factor: 11.528

2.  NCCN Clinical Practice Guidelines Acute myeloid leukemia.

Authors:  Margaret R O'Donnell; Camille N Abboud; Jessica Altman; Frederick R Appelbaum; Daniel A Arber; Eyal Attar; Uma Borate; Steven E Coutre; Lloyd E Damon; Salil Goorha; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Michael M Millenson; Joseph O Moore; Farhad Ravandi; Paul J Shami; B Douglas Smith; Richard M Stone; Stephen A Strickland; Martin S Tallman; Eunice S Wang; Maoko Naganuma; Kristina M Gregory
Journal:  J Natl Compr Canc Netw       Date:  2012-08       Impact factor: 11.908

3.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.

Authors:  Bruno C Medeiros; Megan Othus; Min Fang; Diane Roulston; Frederick R Appelbaum
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

4.  Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.

Authors:  Xueyan Chen; Hu Xie; Brent L Wood; Roland B Walter; John M Pagel; Pamela S Becker; Vicky K Sandhu; Janis L Abkowitz; Frederick R Appelbaum; Elihu H Estey
Journal:  J Clin Oncol       Date:  2015-03-02       Impact factor: 44.544

5.  Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB.

Authors:  E H Estey; Y Shen; P F Thall
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

6.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

Authors:  Bruce D Cheson; John M Bennett; Kenneth J Kopecky; Thomas Büchner; Cheryl L Willman; Elihu H Estey; Charles A Schiffer; Hartmut Doehner; Martin S Tallman; T Andrew Lister; Francesco Lo-Coco; Roel Willemze; Andrea Biondi; Wolfgang Hiddemann; Richard A Larson; Bob Löwenberg; Miguel A Sanz; David R Head; Ryuzo Ohno; Clara D Bloomfield; Francesco LoCocco
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

7.  Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemia.

Authors:  Masamitsu Yanada; Gautam Borthakur; Guillermo Garcia-Manero; Farhad Ravandi; Stefan Faderl; Sherry Pierce; Hagop Kantarjian; Elihu Estey
Journal:  Leuk Res       Date:  2008-04-10       Impact factor: 3.156
  7 in total
  3 in total

Review 1.  Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.

Authors:  Mary-Elizabeth Percival; Catherine Lai; Elihu Estey; Christopher S Hourigan
Journal:  Blood Rev       Date:  2017-02-02       Impact factor: 8.250

2.  How good are we at predicting the fate of someone with acute myeloid leukaemia?

Authors:  E Estey; R P Gale
Journal:  Leukemia       Date:  2017-03-17       Impact factor: 11.528

3.  Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia.

Authors:  Qingkai Dai; Rui Shi; Ge Zhang; Hui Yang; Yuefang Wang; Lei Ye; Luyun Peng; Siqi Guo; Jiajing He; Yongmei Jiang
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.